Arbutus Biopharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Arbutus Biopharma is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.15M	$ 4.66M	$ 3.88M	$ 5.51M	$ 6.25M
Gross Profit	$ 2.15M	$ 4.66M	$ 4.65M	$ 6.69M	$ 6.25M
EBIT	$ -19.27M	$ -20.06M	$ -16.92M	$ -16.14M	$ -22.05M
EBITDA	$ -19.53M	$ -20.35M	$ -17.11M	$ -16.19M	$ -21.99M
Net Income Common Stockholders	$ -20.60M	$ -19.11M	$ -17.09M	$ 32.17M	$ -21.42M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 126.00M	$ 134.18M	$ 152.48M	$ 146.73M	$ 146.91M
Total Assets	$ 144.40M	$ 158.64M	$ 176.82M	$ 191.22M	$ 195.42M
Total Debt	$ 1.77M	$ 1.91M	$ 2.04M	$ 2.12M	$ 2.19M
Net Debt	$ -124.23M	$ -132.27M	$ -150.44M	$ -144.61M	$ -144.73M
Total Liabilities	$ 38.38M	$ 39.30M	$ 42.13M	$ 47.31M	$ 195.42M
Stockholders Equity	$ 106.02M	$ 119.34M	$ 134.69M	$ 143.91M	$ 136.85M
Cash Flow	-
Free Cash Flow	$ -17.29M	$ -22.16M	$ -19.78M	$ -27.69M	$ -19.40M
Operating Cash Flow	$ -17.29M	$ -22.15M	$ -18.92M	$ -27.57M	$ -19.25M
Investing Cash Flow	$ 22.23M	$ 10.79M	$ 805.00K	$ 16.95M	$ 14.91M
Financing Cash Flow	$ 3.81M	$ 1.68M	$ 4.74M	$ 20.42M	$ 11.08M

Currency in USD

Arbutus Biopharma Earnings and Revenue History

Income Statement >

Arbutus Biopharma Debt to Assets

Balance Sheet >

Arbutus Biopharma Cash Flow

Cash Flow >

Arbutus Biopharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing